Merck KGaA - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Merck KGaA required for business and competitor intelligence needs
A study of the major internal and external factors affecting Merck KGaA in the form of a SWOT analysis
An in-depth view of the business model of Merck KGaA including a breakdown and examination of key business segments
Intelligence on Merck KGaA’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Merck KGaA, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Merck KGaA (or 'the group') is a leading company for high-tech products in the pharmaceutical and chemical sectors. The Merck family holds an approximately 70% interest in the group. Merck KGaA operates in 66 countries across the world. It is headquartered in Darmstadt, Germany, and employed 39,639 people as of December 31, 2014. The group recorded revenues of E11,500.8 million ($15,278.8 million) during the financial year ended December 2014 (FY2014), an increase of 3.7% over FY2013. The operating profit of the group was E1,762 million ($2,340.8 million) in FY2014, an increase of 9.4% over FY2013. The net profit of the group was E1,157.3 million ($1,537.5 million) in FY2014, a decrease of 3.7% compared to FY2013.
Reasons to Purchase:
Gain understanding of Merck KGaA and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Merck KGaA as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Merck KGaA’s business structure, strategy and prospects